BlackRock Health Sciences Trust (BME)

Data as of Feb 3, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch BME

See up to 3 months of BME. The 7-day demo opens the 1M and 3M ranges and puts BME on your watchlist.

Start 7-day demo

Latest BME insider trades

Xiang Liu
Option exercise389.1 sh
Jan 30, 2026
Xiang Liu
Derivative$16K
Jan 30, 2026
Xiang Liu
Grant or award

About BlackRock Health Sciences Trust (BME)

SEC filings for BME on EDGAR

BME Form 4 activity by transaction type, last 90 days

No Form 4 activity for BME in the last 90 days.

BME insider transactions (Form 4)

2 Form 4 filings on record, the earliest from Feb 3, 2026, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Jan 30, 2026	Xiang Liu	Option exercise	Common Stock	389.1	-^{footnote F1,F2,F3,F4}	-
Jan 30, 2026	Xiang Liu	Derivative	Common Stock	389.1	$41.87^{footnote F1,F2,F3,F4}	$16K
Jan 30, 2026	Xiang Liu	Grant or award	Phantom Shares	372.96	$41.87	$16K
Jan 30, 2026	Xiang Liu	Option exercise	Phantom Shares	202.6	-^{footnote F1,F2}	-
Jan 30, 2026	Xiang Liu	Option exercise	Phantom Shares	86.57	-^{footnote F1,F3}	-
Jan 30, 2026	Xiang Liu	Option exercise	Phantom Shares	99.93	-^{footnote F1,F4}	-
Footnote F1 (price): A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. Footnote F2 (price): As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Footnote F3 (price): As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Footnote F4 (price): As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
Jan 30, 2026	H. Erin Xie	Option exercise	Common Stock	11,450	-^{footnote F1,F2,F3,F4}	-
Jan 30, 2026	H. Erin Xie	Derivative	Common Stock	11,450	$41.87^{footnote F1,F2,F3,F4}	$479K
Jan 30, 2026	H. Erin Xie	Grant or award	Phantom Shares	6,379	$41.87	$267K
Jan 30, 2026	H. Erin Xie	Option exercise	Phantom Shares	3,452	-^{footnote F1,F2}	-
Jan 30, 2026	H. Erin Xie	Option exercise	Phantom Shares	3,013	-^{footnote F1,F3}	-
Jan 30, 2026	H. Erin Xie	Option exercise	Phantom Shares	4,985	-^{footnote F1,F4}	-
Footnote F1 (price): A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. Footnote F2 (price): As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Footnote F3 (price): As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Footnote F4 (price): As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.

BME insider trading FAQ

What is the latest insider trade for BME?

BlackRock Health Sciences Trust (BME) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-03. The full record for BME runs to 2 Form 4 filings, the earliest from 2026-02-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying BME stock?

No insider purchases of BME were filed in the last 90 days.

How many insiders are selling BME stock?

No insider sales of BME were filed in the last 90 days.

Where can I see BME SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects BME Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Feb 3, 2026 - Xiang Liu view on EDGAR
Feb 3, 2026 - H. Erin Xie view on EDGAR

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity by sector: Where insider buying and selling is concentrated across the eleven GICS sectors.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow BME with a 7-day demo

BME on your watchlist
Every BME Form 4 filing on record
Up to 3 months of BME price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Jan 30, 2026

Xiang Liu

Option exercise

Common Stock

389.1

-^{footnote F1,F2,F3,F4}

Jan 30, 2026

Xiang Liu

Derivative

Common Stock

389.1

$41.87^{footnote F1,F2,F3,F4}

$16K

Jan 30, 2026

Xiang Liu

Grant or award

Phantom Shares

372.96

$41.87

$16K

Jan 30, 2026

Xiang Liu

Option exercise

Phantom Shares

202.6

-^{footnote F1,F2}

Jan 30, 2026

Xiang Liu

Option exercise

Phantom Shares

86.57

-^{footnote F1,F3}

Jan 30, 2026

Xiang Liu

Option exercise

Phantom Shares

99.93

-^{footnote F1,F4}

Footnote F1 (price): A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
Footnote F2 (price): As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
Footnote F3 (price): As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
Footnote F4 (price): As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.

Jan 30, 2026

H. Erin Xie

Option exercise

Common Stock

11,450

-^{footnote F1,F2,F3,F4}

Jan 30, 2026

H. Erin Xie

Derivative

Common Stock

11,450

$41.87^{footnote F1,F2,F3,F4}

$479K

Jan 30, 2026

H. Erin Xie

Grant or award

Phantom Shares

6,379

$41.87

$267K

Jan 30, 2026

H. Erin Xie

Option exercise

Phantom Shares

3,452

-^{footnote F1,F2}

Jan 30, 2026

H. Erin Xie

Option exercise

Phantom Shares

3,013

-^{footnote F1,F3}

Jan 30, 2026

H. Erin Xie

Option exercise

Phantom Shares

4,985

-^{footnote F1,F4}

Footnote F1 (price): A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
Footnote F2 (price): As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
Footnote F3 (price): As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
Footnote F4 (price): As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.